Combining Plasma Extracellular Vesicle Let-7b-5p, miR-184 and Circulating miR-22-3p Levels for NSCLC Diagnosis and Drug Resistance Prediction

0
293
Targeting Hsa-miR-22-3p and Hsa-miR-184 desensitized EGFR-mutated NSCLC cells to Osimertinib.
[Scientific Reports]
Full Article